Allez à nos transactions
Alimentation et Breuvages | Soins de la Santé

Harmonium International Inc. has sold a minority stake to Lallemand

Laboratories Stand has sold a minority sake in Harmonium International Inc. to Lallemand for US$30 million.

Lallemand is a global leader in the development, production and marketing of yeast, bacteria and specialty ingredients.

Laboratoires Standa develops and commercializes products which maintain the original quality of food products (ATCO and SANICO ranges) and brings under control the fermentation of dairy products.

Oaklins' team in Montreal, Canada, acted as the exclusive advisor to the seller in this transaction.

Parties prenantes

Contacter l'équipe de la transaction

Sebastien Nadeau

Associé directeur
Montréal, Canada
Oaklins Canada

Transactions connexes

St. Claraspital AG has been acquired by University Hospital Basel
Soins de la Santé

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

En apprendre plus
RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
Placements Privés | Soins de la Santé | TMT

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital

RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.

En apprendre plus
Cerbios-Pharma has been acquired by HAS Healthcare
Soins de la Santé

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

En apprendre plus